nodes	percent_of_prediction	percent_of_DWPC	metapath
Darifenacin—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.114	0.216	CbGbCtD
Darifenacin—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0862	0.164	CbGbCtD
Darifenacin—CYP3A4—Betamethasone—ankylosing spondylitis	0.074	0.14	CbGbCtD
Darifenacin—CYP3A4—Prednisolone—ankylosing spondylitis	0.073	0.139	CbGbCtD
Darifenacin—CYP3A4—Prednisone—ankylosing spondylitis	0.0689	0.131	CbGbCtD
Darifenacin—CYP2D6—Dexamethasone—ankylosing spondylitis	0.0677	0.129	CbGbCtD
Darifenacin—CYP3A4—Dexamethasone—ankylosing spondylitis	0.043	0.0817	CbGbCtD
Darifenacin—Mouth ulceration—Methotrexate—ankylosing spondylitis	0.0028	0.00592	CcSEcCtD
Darifenacin—Weight increased—Triamcinolone—ankylosing spondylitis	0.00268	0.00566	CcSEcCtD
Darifenacin—Weight increased—Methylprednisolone—ankylosing spondylitis	0.00267	0.00565	CcSEcCtD
Darifenacin—Infestation NOS—Methylprednisolone—ankylosing spondylitis	0.00262	0.00553	CcSEcCtD
Darifenacin—Infestation—Methylprednisolone—ankylosing spondylitis	0.00262	0.00553	CcSEcCtD
Darifenacin—Face oedema—Prednisone—ankylosing spondylitis	0.0026	0.00549	CcSEcCtD
Darifenacin—Sweating—Methylprednisolone—ankylosing spondylitis	0.00251	0.0053	CcSEcCtD
Darifenacin—Visual impairment—Prednisolone—ankylosing spondylitis	0.00247	0.00522	CcSEcCtD
Darifenacin—Dry skin—Prednisone—ankylosing spondylitis	0.00247	0.00521	CcSEcCtD
Darifenacin—Weight increased—Dexamethasone—ankylosing spondylitis	0.00243	0.00514	CcSEcCtD
Darifenacin—Weight increased—Betamethasone—ankylosing spondylitis	0.00243	0.00514	CcSEcCtD
Darifenacin—Alanine aminotransferase increased—Prednisone—ankylosing spondylitis	0.00238	0.00502	CcSEcCtD
Darifenacin—Visual disturbance—Methotrexate—ankylosing spondylitis	0.00237	0.00502	CcSEcCtD
Darifenacin—Rhinitis—Triamcinolone—ankylosing spondylitis	0.00236	0.00499	CcSEcCtD
Darifenacin—Rhinitis—Methylprednisolone—ankylosing spondylitis	0.00236	0.00498	CcSEcCtD
Darifenacin—Hallucination—Methylprednisolone—ankylosing spondylitis	0.00234	0.00494	CcSEcCtD
Darifenacin—Pharyngitis—Triamcinolone—ankylosing spondylitis	0.00234	0.00494	CcSEcCtD
Darifenacin—Cerebrovascular accident—Methotrexate—ankylosing spondylitis	0.0023	0.00485	CcSEcCtD
Darifenacin—Visual impairment—Methylprednisolone—ankylosing spondylitis	0.00227	0.00479	CcSEcCtD
Darifenacin—Eye disorder—Methylprednisolone—ankylosing spondylitis	0.0022	0.00464	CcSEcCtD
Darifenacin—Erectile dysfunction—Prednisone—ankylosing spondylitis	0.00214	0.00453	CcSEcCtD
Darifenacin—Angiopathy—Methylprednisolone—ankylosing spondylitis	0.00213	0.00451	CcSEcCtD
Darifenacin—Hallucination—Betamethasone—ankylosing spondylitis	0.00213	0.00449	CcSEcCtD
Darifenacin—Hallucination—Dexamethasone—ankylosing spondylitis	0.00213	0.00449	CcSEcCtD
Darifenacin—Mediastinal disorder—Methylprednisolone—ankylosing spondylitis	0.00212	0.00448	CcSEcCtD
Darifenacin—Weight increased—Prednisone—ankylosing spondylitis	0.00212	0.00447	CcSEcCtD
Darifenacin—Vision blurred—Prednisolone—ankylosing spondylitis	0.0021	0.00444	CcSEcCtD
Darifenacin—Visual impairment—Betamethasone—ankylosing spondylitis	0.00206	0.00435	CcSEcCtD
Darifenacin—Visual impairment—Dexamethasone—ankylosing spondylitis	0.00206	0.00435	CcSEcCtD
Darifenacin—Mental disorder—Methylprednisolone—ankylosing spondylitis	0.00206	0.00435	CcSEcCtD
Darifenacin—Angioedema—Prednisolone—ankylosing spondylitis	0.00204	0.00431	CcSEcCtD
Darifenacin—Breast disorder—Methotrexate—ankylosing spondylitis	0.00203	0.00429	CcSEcCtD
Darifenacin—Dysgeusia—Triamcinolone—ankylosing spondylitis	0.00201	0.00424	CcSEcCtD
Darifenacin—Syncope—Prednisolone—ankylosing spondylitis	0.002	0.00423	CcSEcCtD
Darifenacin—Eye disorder—Dexamethasone—ankylosing spondylitis	0.002	0.00422	CcSEcCtD
Darifenacin—Eye disorder—Betamethasone—ankylosing spondylitis	0.002	0.00422	CcSEcCtD
Darifenacin—Back pain—Triamcinolone—ankylosing spondylitis	0.00199	0.00419	CcSEcCtD
Darifenacin—Loss of consciousness—Prednisolone—ankylosing spondylitis	0.00196	0.00414	CcSEcCtD
Darifenacin—Angiopathy—Betamethasone—ankylosing spondylitis	0.00194	0.0041	CcSEcCtD
Darifenacin—Angiopathy—Dexamethasone—ankylosing spondylitis	0.00194	0.0041	CcSEcCtD
Darifenacin—Hypertension—Prednisolone—ankylosing spondylitis	0.00193	0.00407	CcSEcCtD
Darifenacin—Angioedema—Triamcinolone—ankylosing spondylitis	0.00188	0.00396	CcSEcCtD
Darifenacin—Angioedema—Methylprednisolone—ankylosing spondylitis	0.00187	0.00395	CcSEcCtD
Darifenacin—Hallucination—Prednisone—ankylosing spondylitis	0.00185	0.00391	CcSEcCtD
Darifenacin—Syncope—Triamcinolone—ankylosing spondylitis	0.00184	0.00389	CcSEcCtD
Darifenacin—Syncope—Methylprednisolone—ankylosing spondylitis	0.00184	0.00388	CcSEcCtD
Darifenacin—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.00182	0.00385	CcSEcCtD
Darifenacin—Oedema—Prednisolone—ankylosing spondylitis	0.00182	0.00385	CcSEcCtD
Darifenacin—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.0018	0.00381	CcSEcCtD
Darifenacin—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.0018	0.0038	CcSEcCtD
Darifenacin—Shock—Prednisolone—ankylosing spondylitis	0.00179	0.00378	CcSEcCtD
Darifenacin—Erectile dysfunction—Methotrexate—ankylosing spondylitis	0.00179	0.00378	CcSEcCtD
Darifenacin—Cough—Triamcinolone—ankylosing spondylitis	0.00179	0.00378	CcSEcCtD
Darifenacin—Tachycardia—Prednisolone—ankylosing spondylitis	0.00178	0.00375	CcSEcCtD
Darifenacin—Hypertension—Triamcinolone—ankylosing spondylitis	0.00177	0.00374	CcSEcCtD
Darifenacin—Hypertension—Methylprednisolone—ankylosing spondylitis	0.00177	0.00373	CcSEcCtD
Darifenacin—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.00176	0.00372	CcSEcCtD
Darifenacin—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.00174	0.00368	CcSEcCtD
Darifenacin—Eye disorder—Prednisone—ankylosing spondylitis	0.00174	0.00368	CcSEcCtD
Darifenacin—Infestation NOS—Methotrexate—ankylosing spondylitis	0.00173	0.00366	CcSEcCtD
Darifenacin—Infestation—Methotrexate—ankylosing spondylitis	0.00173	0.00366	CcSEcCtD
Darifenacin—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.00173	0.00366	CcSEcCtD
Darifenacin—Dry mouth—Triamcinolone—ankylosing spondylitis	0.00171	0.00361	CcSEcCtD
Darifenacin—Angioedema—Dexamethasone—ankylosing spondylitis	0.0017	0.00359	CcSEcCtD
Darifenacin—Angioedema—Betamethasone—ankylosing spondylitis	0.0017	0.00359	CcSEcCtD
Darifenacin—Stomatitis—Methotrexate—ankylosing spondylitis	0.00169	0.00357	CcSEcCtD
Darifenacin—Angiopathy—Prednisone—ankylosing spondylitis	0.00169	0.00357	CcSEcCtD
Darifenacin—Confusional state—Methylprednisolone—ankylosing spondylitis	0.00169	0.00356	CcSEcCtD
Darifenacin—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.00168	0.00354	CcSEcCtD
Darifenacin—Oedema—Triamcinolone—ankylosing spondylitis	0.00168	0.00354	CcSEcCtD
Darifenacin—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.00167	0.00353	CcSEcCtD
Darifenacin—Syncope—Betamethasone—ankylosing spondylitis	0.00167	0.00353	CcSEcCtD
Darifenacin—Syncope—Dexamethasone—ankylosing spondylitis	0.00167	0.00353	CcSEcCtD
Darifenacin—Infection—Triamcinolone—ankylosing spondylitis	0.00166	0.00351	CcSEcCtD
Darifenacin—Sweating—Methotrexate—ankylosing spondylitis	0.00166	0.00351	CcSEcCtD
Darifenacin—Infection—Methylprednisolone—ankylosing spondylitis	0.00166	0.00351	CcSEcCtD
Darifenacin—Shock—Triamcinolone—ankylosing spondylitis	0.00165	0.00348	CcSEcCtD
Darifenacin—Insomnia—Prednisolone—ankylosing spondylitis	0.00165	0.00348	CcSEcCtD
Darifenacin—Shock—Methylprednisolone—ankylosing spondylitis	0.00164	0.00347	CcSEcCtD
Darifenacin—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.00164	0.00346	CcSEcCtD
Darifenacin—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.00164	0.00346	CcSEcCtD
Darifenacin—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.00164	0.00346	CcSEcCtD
Darifenacin—Tachycardia—Triamcinolone—ankylosing spondylitis	0.00163	0.00345	CcSEcCtD
Darifenacin—Mental disorder—Prednisone—ankylosing spondylitis	0.00163	0.00345	CcSEcCtD
Darifenacin—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.00163	0.00344	CcSEcCtD
Darifenacin—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.00162	0.00343	CcSEcCtD
Darifenacin—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.00162	0.00342	CcSEcCtD
Darifenacin—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.00162	0.00341	CcSEcCtD
Darifenacin—Hypertension—Betamethasone—ankylosing spondylitis	0.00161	0.0034	CcSEcCtD
Darifenacin—Hypertension—Dexamethasone—ankylosing spondylitis	0.00161	0.0034	CcSEcCtD
Darifenacin—Pain—Prednisolone—ankylosing spondylitis	0.00156	0.00329	CcSEcCtD
Darifenacin—Pharyngitis—Methotrexate—ankylosing spondylitis	0.00155	0.00326	CcSEcCtD
Darifenacin—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.00154	0.00325	CcSEcCtD
Darifenacin—Vision blurred—Prednisone—ankylosing spondylitis	0.00153	0.00323	CcSEcCtD
Darifenacin—Urethral disorder—Methotrexate—ankylosing spondylitis	0.00153	0.00322	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.00153	0.00322	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.00152	0.00322	CcSEcCtD
Darifenacin—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.00152	0.00321	CcSEcCtD
Darifenacin—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.00152	0.00321	CcSEcCtD
Darifenacin—Oedema—Dexamethasone—ankylosing spondylitis	0.00152	0.00321	CcSEcCtD
Darifenacin—Oedema—Betamethasone—ankylosing spondylitis	0.00152	0.00321	CcSEcCtD
Darifenacin—Insomnia—Triamcinolone—ankylosing spondylitis	0.00152	0.0032	CcSEcCtD
Darifenacin—Insomnia—Methylprednisolone—ankylosing spondylitis	0.00151	0.00319	CcSEcCtD
Darifenacin—Infection—Betamethasone—ankylosing spondylitis	0.00151	0.00319	CcSEcCtD
Darifenacin—Infection—Dexamethasone—ankylosing spondylitis	0.00151	0.00319	CcSEcCtD
Darifenacin—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.0015	0.00317	CcSEcCtD
Darifenacin—Visual impairment—Methotrexate—ankylosing spondylitis	0.0015	0.00317	CcSEcCtD
Darifenacin—Shock—Betamethasone—ankylosing spondylitis	0.0015	0.00316	CcSEcCtD
Darifenacin—Shock—Dexamethasone—ankylosing spondylitis	0.0015	0.00316	CcSEcCtD
Darifenacin—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.00149	0.00315	CcSEcCtD
Darifenacin—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.00149	0.00315	CcSEcCtD
Darifenacin—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.00149	0.00315	CcSEcCtD
Darifenacin—Tachycardia—Betamethasone—ankylosing spondylitis	0.00148	0.00313	CcSEcCtD
Darifenacin—Tachycardia—Dexamethasone—ankylosing spondylitis	0.00148	0.00313	CcSEcCtD
Darifenacin—Angioedema—Prednisone—ankylosing spondylitis	0.00148	0.00313	CcSEcCtD
Darifenacin—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.00147	0.00311	CcSEcCtD
Darifenacin—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.00147	0.00311	CcSEcCtD
Darifenacin—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.00147	0.00311	CcSEcCtD
Darifenacin—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.00147	0.0031	CcSEcCtD
Darifenacin—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.00147	0.0031	CcSEcCtD
Darifenacin—Eye disorder—Methotrexate—ankylosing spondylitis	0.00146	0.00307	CcSEcCtD
Darifenacin—Syncope—Prednisone—ankylosing spondylitis	0.00145	0.00307	CcSEcCtD
Darifenacin—Pain—Triamcinolone—ankylosing spondylitis	0.00143	0.00302	CcSEcCtD
Darifenacin—Loss of consciousness—Prednisone—ankylosing spondylitis	0.00143	0.00301	CcSEcCtD
Darifenacin—Angiopathy—Methotrexate—ankylosing spondylitis	0.00141	0.00298	CcSEcCtD
Darifenacin—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.0014	0.00296	CcSEcCtD
Darifenacin—Hypertension—Prednisone—ankylosing spondylitis	0.0014	0.00296	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.00138	0.00292	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.00138	0.00292	CcSEcCtD
Darifenacin—Arthralgia—Prednisone—ankylosing spondylitis	0.00138	0.00292	CcSEcCtD
Darifenacin—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.00138	0.00291	CcSEcCtD
Darifenacin—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.00138	0.00291	CcSEcCtD
Darifenacin—Insomnia—Dexamethasone—ankylosing spondylitis	0.00137	0.0029	CcSEcCtD
Darifenacin—Insomnia—Betamethasone—ankylosing spondylitis	0.00137	0.0029	CcSEcCtD
Darifenacin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.00137	0.0029	CcSEcCtD
Darifenacin—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.00137	0.00289	CcSEcCtD
Darifenacin—Mental disorder—Methotrexate—ankylosing spondylitis	0.00136	0.00288	CcSEcCtD
Darifenacin—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.00134	0.00283	CcSEcCtD
Darifenacin—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.00134	0.00283	CcSEcCtD
Darifenacin—Dyspepsia—Betamethasone—ankylosing spondylitis	0.00134	0.00283	CcSEcCtD
Darifenacin—Dysgeusia—Methotrexate—ankylosing spondylitis	0.00133	0.0028	CcSEcCtD
Darifenacin—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.00132	0.00279	CcSEcCtD
Darifenacin—Oedema—Prednisone—ankylosing spondylitis	0.00132	0.00279	CcSEcCtD
Darifenacin—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.00132	0.00279	CcSEcCtD
Darifenacin—Infection—Prednisone—ankylosing spondylitis	0.00131	0.00278	CcSEcCtD
Darifenacin—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.00131	0.00277	CcSEcCtD
Darifenacin—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.00131	0.00277	CcSEcCtD
Darifenacin—Back pain—Methotrexate—ankylosing spondylitis	0.00131	0.00277	CcSEcCtD
Darifenacin—Shock—Prednisone—ankylosing spondylitis	0.0013	0.00275	CcSEcCtD
Darifenacin—Pain—Dexamethasone—ankylosing spondylitis	0.0013	0.00274	CcSEcCtD
Darifenacin—Pain—Betamethasone—ankylosing spondylitis	0.0013	0.00274	CcSEcCtD
Darifenacin—Nervous system disorder—Prednisone—ankylosing spondylitis	0.0013	0.00274	CcSEcCtD
Darifenacin—Tachycardia—Prednisone—ankylosing spondylitis	0.00129	0.00273	CcSEcCtD
Darifenacin—Skin disorder—Prednisone—ankylosing spondylitis	0.00129	0.00271	CcSEcCtD
Darifenacin—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.00128	0.0027	CcSEcCtD
Darifenacin—Vision blurred—Methotrexate—ankylosing spondylitis	0.00128	0.0027	CcSEcCtD
Darifenacin—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.00125	0.00264	CcSEcCtD
Darifenacin—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.00125	0.00264	CcSEcCtD
Darifenacin—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.00124	0.00262	CcSEcCtD
Darifenacin—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.00124	0.00262	CcSEcCtD
Darifenacin—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.00123	0.00261	CcSEcCtD
Darifenacin—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.00123	0.0026	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.00121	0.00255	CcSEcCtD
Darifenacin—Dizziness—Prednisolone—ankylosing spondylitis	0.0012	0.00254	CcSEcCtD
Darifenacin—Asthenia—Triamcinolone—ankylosing spondylitis	0.0012	0.00254	CcSEcCtD
Darifenacin—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.0012	0.00254	CcSEcCtD
Darifenacin—Abdominal pain—Betamethasone—ankylosing spondylitis	0.0012	0.00254	CcSEcCtD
Darifenacin—Asthenia—Methylprednisolone—ankylosing spondylitis	0.0012	0.00253	CcSEcCtD
Darifenacin—Insomnia—Prednisone—ankylosing spondylitis	0.0012	0.00253	CcSEcCtD
Darifenacin—Pruritus—Triamcinolone—ankylosing spondylitis	0.00119	0.0025	CcSEcCtD
Darifenacin—Cough—Methotrexate—ankylosing spondylitis	0.00118	0.0025	CcSEcCtD
Darifenacin—Pruritus—Methylprednisolone—ankylosing spondylitis	0.00118	0.0025	CcSEcCtD
Darifenacin—Dyspepsia—Prednisone—ankylosing spondylitis	0.00117	0.00246	CcSEcCtD
Darifenacin—Arthralgia—Methotrexate—ankylosing spondylitis	0.00115	0.00244	CcSEcCtD
Darifenacin—Rash—Prednisolone—ankylosing spondylitis	0.00115	0.00243	CcSEcCtD
Darifenacin—Dermatitis—Prednisolone—ankylosing spondylitis	0.00115	0.00242	CcSEcCtD
Darifenacin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.00115	0.00242	CcSEcCtD
Darifenacin—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00114	0.00241	CcSEcCtD
Darifenacin—Headache—Prednisolone—ankylosing spondylitis	0.00114	0.00241	CcSEcCtD
Darifenacin—Constipation—Prednisone—ankylosing spondylitis	0.00113	0.00239	CcSEcCtD
Darifenacin—Confusional state—Methotrexate—ankylosing spondylitis	0.00112	0.00236	CcSEcCtD
Darifenacin—Dizziness—Triamcinolone—ankylosing spondylitis	0.00111	0.00234	CcSEcCtD
Darifenacin—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.00111	0.00234	CcSEcCtD
Darifenacin—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00111	0.00233	CcSEcCtD
Darifenacin—Infection—Methotrexate—ankylosing spondylitis	0.0011	0.00232	CcSEcCtD
Darifenacin—Feeling abnormal—Prednisone—ankylosing spondylitis	0.00109	0.0023	CcSEcCtD
Darifenacin—Asthenia—Dexamethasone—ankylosing spondylitis	0.00109	0.0023	CcSEcCtD
Darifenacin—Asthenia—Betamethasone—ankylosing spondylitis	0.00109	0.0023	CcSEcCtD
Darifenacin—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.00108	0.00229	CcSEcCtD
Darifenacin—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.00108	0.00229	CcSEcCtD
Darifenacin—Nausea—Prednisolone—ankylosing spondylitis	0.00108	0.00228	CcSEcCtD
Darifenacin—Pruritus—Dexamethasone—ankylosing spondylitis	0.00108	0.00227	CcSEcCtD
Darifenacin—Pruritus—Betamethasone—ankylosing spondylitis	0.00108	0.00227	CcSEcCtD
Darifenacin—Skin disorder—Methotrexate—ankylosing spondylitis	0.00107	0.00227	CcSEcCtD
Darifenacin—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.00107	0.00226	CcSEcCtD
Darifenacin—Vomiting—Triamcinolone—ankylosing spondylitis	0.00107	0.00225	CcSEcCtD
Darifenacin—Vomiting—Methylprednisolone—ankylosing spondylitis	0.00106	0.00224	CcSEcCtD
Darifenacin—Rash—Triamcinolone—ankylosing spondylitis	0.00106	0.00223	CcSEcCtD
Darifenacin—Dermatitis—Triamcinolone—ankylosing spondylitis	0.00106	0.00223	CcSEcCtD
Darifenacin—Rash—Methylprednisolone—ankylosing spondylitis	0.00105	0.00223	CcSEcCtD
Darifenacin—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.00105	0.00222	CcSEcCtD
Darifenacin—Headache—Triamcinolone—ankylosing spondylitis	0.00105	0.00222	CcSEcCtD
Darifenacin—Headache—Methylprednisolone—ankylosing spondylitis	0.00105	0.00221	CcSEcCtD
Darifenacin—Abdominal pain—Prednisone—ankylosing spondylitis	0.00105	0.00221	CcSEcCtD
Darifenacin—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.00104	0.0022	CcSEcCtD
Darifenacin—Diarrhoea—Betamethasone—ankylosing spondylitis	0.00104	0.0022	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.00101	0.00213	CcSEcCtD
Darifenacin—Dizziness—Betamethasone—ankylosing spondylitis	0.00101	0.00212	CcSEcCtD
Darifenacin—Dizziness—Dexamethasone—ankylosing spondylitis	0.00101	0.00212	CcSEcCtD
Darifenacin—Insomnia—Methotrexate—ankylosing spondylitis	0.001	0.00211	CcSEcCtD
Darifenacin—Nausea—Triamcinolone—ankylosing spondylitis	0.000995	0.0021	CcSEcCtD
Darifenacin—Nausea—Methylprednisolone—ankylosing spondylitis	0.000993	0.0021	CcSEcCtD
Darifenacin—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000986	0.00208	CcSEcCtD
Darifenacin—Somnolence—Methotrexate—ankylosing spondylitis	0.000983	0.00208	CcSEcCtD
Darifenacin—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000975	0.00206	CcSEcCtD
Darifenacin—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000974	0.00206	CcSEcCtD
Darifenacin—Vomiting—Dexamethasone—ankylosing spondylitis	0.000966	0.00204	CcSEcCtD
Darifenacin—Vomiting—Betamethasone—ankylosing spondylitis	0.000966	0.00204	CcSEcCtD
Darifenacin—Rash—Dexamethasone—ankylosing spondylitis	0.000958	0.00202	CcSEcCtD
Darifenacin—Rash—Betamethasone—ankylosing spondylitis	0.000958	0.00202	CcSEcCtD
Darifenacin—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000957	0.00202	CcSEcCtD
Darifenacin—Dermatitis—Betamethasone—ankylosing spondylitis	0.000957	0.00202	CcSEcCtD
Darifenacin—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000955	0.00202	CcSEcCtD
Darifenacin—Headache—Betamethasone—ankylosing spondylitis	0.000952	0.00201	CcSEcCtD
Darifenacin—Headache—Dexamethasone—ankylosing spondylitis	0.000952	0.00201	CcSEcCtD
Darifenacin—Asthenia—Prednisone—ankylosing spondylitis	0.00095	0.00201	CcSEcCtD
Darifenacin—Pain—Methotrexate—ankylosing spondylitis	0.000946	0.002	CcSEcCtD
Darifenacin—Pruritus—Prednisone—ankylosing spondylitis	0.000936	0.00198	CcSEcCtD
Darifenacin—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000912	0.00192	CcSEcCtD
Darifenacin—Diarrhoea—Prednisone—ankylosing spondylitis	0.000906	0.00191	CcSEcCtD
Darifenacin—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000905	0.00191	CcSEcCtD
Darifenacin—Nausea—Betamethasone—ankylosing spondylitis	0.000903	0.00191	CcSEcCtD
Darifenacin—Nausea—Dexamethasone—ankylosing spondylitis	0.000903	0.00191	CcSEcCtD
Darifenacin—Dizziness—Prednisone—ankylosing spondylitis	0.000875	0.00185	CcSEcCtD
Darifenacin—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000874	0.00185	CcSEcCtD
Darifenacin—Vomiting—Prednisone—ankylosing spondylitis	0.000842	0.00178	CcSEcCtD
Darifenacin—Rash—Prednisone—ankylosing spondylitis	0.000835	0.00176	CcSEcCtD
Darifenacin—Dermatitis—Prednisone—ankylosing spondylitis	0.000834	0.00176	CcSEcCtD
Darifenacin—Headache—Prednisone—ankylosing spondylitis	0.000829	0.00175	CcSEcCtD
Darifenacin—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000815	0.00172	CcSEcCtD
Darifenacin—Asthenia—Methotrexate—ankylosing spondylitis	0.000794	0.00168	CcSEcCtD
Darifenacin—Nausea—Prednisone—ankylosing spondylitis	0.000786	0.00166	CcSEcCtD
Darifenacin—Pruritus—Methotrexate—ankylosing spondylitis	0.000783	0.00165	CcSEcCtD
Darifenacin—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000757	0.0016	CcSEcCtD
Darifenacin—Dizziness—Methotrexate—ankylosing spondylitis	0.000731	0.00154	CcSEcCtD
Darifenacin—Vomiting—Methotrexate—ankylosing spondylitis	0.000703	0.00149	CcSEcCtD
Darifenacin—Rash—Methotrexate—ankylosing spondylitis	0.000697	0.00147	CcSEcCtD
Darifenacin—Dermatitis—Methotrexate—ankylosing spondylitis	0.000697	0.00147	CcSEcCtD
Darifenacin—Headache—Methotrexate—ankylosing spondylitis	0.000693	0.00146	CcSEcCtD
Darifenacin—Nausea—Methotrexate—ankylosing spondylitis	0.000657	0.00139	CcSEcCtD
